
UFSH (n = 86)

TCGA (n = 49)


HCVHCC (n = 11)

EtOHHCC (n = 11)

HCVcirrhosis (n = 10)

EtOHcirrhosis (n = 10)

Normal liver (n = 44)

HCVHCC (n = 20)

EtOHHCC (n = 20)

Noncancerous Liver (n = 9)


Age [mean (SD)]

57.6 (7.2)

64.5 (7.5)

54.2 (5.4)

63.0 (6.8)

57.7 (16.0)

59.7 (11.2)

68. 4 (6.6)

70.3 (11.4)

p value^{1}

0.20

Sex [Freq. (%)]

Female

2 (18.2)

2 (18.2)

2 (20.0)

1 (10.0)

19 (43.2)

4 (20.0)

3 (15.0)

5 (55.6)

Male

9 (81.8)

9 (81.8)

8 (80.0)

9 (90.0)

25 (56.8)

16 (80.0)

17 (85.0)

4 (44.4)

p value^{1}

0.99

Tumor stage [Freq. (%)]

I

3 (27.27)

3 (27.27)

–

–

–

9 (45.0)

9 (45.0)

–

II

4 (36.36)

2 (18.18)

–

–

–

5 (25.0)

4 (20.0)

–

III

3 (27.27)

4 (36.36)

–

–

–

4 (20.0)

5 (25.0)

–

Unknown

1 (9.09)

2 (18.18)

–

–

–

2 (10.0)

2 (10.0)

–

p value^{1}

0.48

 ^{1}p value was calculated using t test for continuous data and chisquared test for categorical data among patients with HCVHCC and EtOHHCC combined